IBM and Symantec join forces to produce a single
product under the Norton AntiVirus trade name.
Symantec licenses IBM technology and patents
IBM to recommend Norton to customers worldwide
Cupertino, CA - May 19, 1998.
IBM and Symantec Corporation announced today that they would combine forces to deliver a single family of anti-virus products which will be marketed under the Norton AntiVirus brand name.
Symantec will license IBM's immune system technology and patents and will combine it with its own technology to produce a range of products, including new solutions to support IBM platforms. As part of the agreement, IBM has also assigned its existing anti-virus customer and OEM contracts to Symantec and will recommend Norton AntiVirus to its corporate customers worldwide as the anti-virus solution of
choice. In addition IBM and Symantec intend to sell and market the Norton AntiVirus product line worldwide.
In a related announcement, Intel said today it is incorporating IBM's anti-virus engine technology into its LANDesk Virus Protect products and other Intel network management products featuring LANDesk Virus Protect functionality.
"Combining IBM's technology with Symantec's brand strength and heritage in the anti-virus sector takes protection against virus infection to a new, higher level," said Phyllis Byrne, vice president of Distributed Systems Services for IBM. "We believe Symantec's current anti-virus products are the best available and will only be strengthened with the addition of our technology. We are confident in recommending the Norton AntiVirus solution to our customers."
Symantec president and CEO, Gordon Eubanks, added: "Corporate
organizations already recognize Symantec and the Norton brand as a solution they can trust to protect against the threat of virus attack. By working with IBM to further develop their immune system technology and incorporate it into a comprehensive range of Norton AntiVirus products, we will offer corporate customers the most comprehensive anti-virus solution available."
Ed Ekstrom, vice president, Intel Small Business and Networking Group and general manager, Systems Management Division, said: "Combining IBM's leading anti-virus scanning technology with our anti-virus policy and management expertise provides our customers the best anti-virus detection, management and protection technology currently
available. We will pursue the possibility of incorporating the virus detection software resulting from the IBM/Symantec alliance when it becomes available."
The alliance with Symantec complements IBM's announcement earlier this month of its eNetwork Software security and directory integration solution, which provides a comprehensive security solution for extending customers' information technology infrastructure to the Worldwide Web. The eNetwork Software security solution leverages IBM's
decades of experience with information security and allows companies with large, complex computer systems to handle their entire range of security needs through one company.
IBM's anti-virus technology, part of the IBM SecureWay comprehensive portfolio of security offerings, has been awarded six patents for inventions, ranging from a neural
network that uses artificial intelligence to detect new viruses automatically to the immune system itself. IBM is the first company to develop an immune system that can detect previously unknown viruses, analyze them, and distribute a cure worldwide, all automatically and within minutes of first discovering new viruses.
Symantec's multi-tier virus protection strategy is the basis for products that protect the enterprise at the desktop, groupware, server, Internet and gateway levels. The Norton AntiVirus product line uses innovative Bloodhound heuristic technology to detect and remove both known and unknown viruses. Norton AntiVirus also includes LiveUpdate, which automatically updates users with the latest virus definitions over the Internet.
For more information, please refer to:
A message from Symantec to current IBM Anti-Virus Subscription customers:
We are pleased to inform you that IBM has entered into a strategic alliance with Symantec Corporation, the intention of which is to combine IBM's Immune System technology with Symantec's award winning, market leading Norton AntiVirus product line. This union between Symantec and IBM will bring virus detection and elimination to a new level of excellence and reliability. As part of this strategic alliance with IBM, Symantec will be offering current subscribers of IBM's antivirus product the opportunity to switch over to the Norton AntiVirus solution at no additional charge.
In the next few weeks all registered IBM Anti-Virus Subscription customers will receive a mailing which will include the Symantec company backgrounder, the Norton AntiVirus family brochure and the Norton AntiVirus Evaluator's CD. This Evaluator's CD contains fully functional, 90-day license versions of Norton AntiVirus. Soon thereafter, you will receive a a special transition kit, including a complete Norton AntiVirus Solutions package. This package will contain all current versions of the Norton AntiVirus product line and will be a vital component of your transition. We will also be including details of how we will help you transition to Norton AntiVirus at no additional charge.
If you have not received the Evaluator's CD by June 1st, please contact Symantec Customer Service at 1-800-745-6054.
IBM Questions and Answers
Question 1: What exactly has been announced by IBM and Symantec?
Answer 1: We've announced a strategic alliance that will combine IBM's exceptional anti-virus technology with the well-known anti-virus products of Symantec. This will allow Symantec to use our technology while providing us with a broader market for our immune system technology. We believe this alliance will provide our customers with one of the best anti-virus solutions available.
Question 2: Is IBM getting out of the anti-virus business?
Answer 2: No, IBM will continue to develop its anti-virus Immune System technology, in collaboration with Symantec. This technology will become a key component of Symantec's offerings. By integrating IBM's leading-edge technology with Symantec's existing suite of security offerings, we can deliver an exceptional anti-virus protection solution to our customers. In addition, IBM will continue to offer services which provide product-independent support and emergency response to virus-related issues.
Question 3: What effect will this announcement have on the Immune System technology research being conducted at IBM Research?
Answer 3: IBM will continue to develop Immune System technology, in a research and development collaboration with Symantec.
Question 4: Symantec does not currently have an OS/2 anti-virus solution that I’m aware of. What do I do for anti-virus protection for my OS/2 systems?
Answer 4: Symantec has agreed to provide a native OS/2 version of their anti-virus product. In the meantime, they will offer the IBM AntiVirus for OS/2 product as an alternative. Symantec has also agreed to provide Lotus Notes Domino support for OS/2, S/390, AIX and OS/400.
Question 5: Some existing customers will need time to test any new platform and to establish an orderly transition plan. Can they continue to use IBM AntiVirus for now?
Answer 5: Yes, they can continue to use IBM AntiVirus. Version 3.0.2 is currently being shipped to existing Subscription Plan and Upgrade Protection customers specifically to provide our long-term customers with a stable platform for this transition. Defect and new signature file support will continue to be provided through year end. However, no further enhancements or upgrade releases are planned. Should a new type of virus become public, protection would come through Symantec. All IBM AntiVirus support expires 12/31/98.
Question 6: If a customer currently licensed for IBM AntiVirus needs additional licenses (rights to copy) to protect newly-purchased systems during a transition period, will they be available?
Answer 6: Both IBM and Symantec understand that the customer transition from IBM's AntiVirus solution to the Norton AntiVirus solution will require some flexibility. Some customers will, for a time, still need to be able to acquire additional licenses of the IBM AntiVirus product.
Working together, IBM and Symantec have established a process that will allow IBM customers access to these additional licenses and assist them in their transition objectives. Symantec has made available specific contacts within each of their worldwide regions to assist IBM in managing the transition of our jointly valued customers.
Question 7: What happens to customers who currently receive periodic upgrades to the IBM AntiVirus product from IBM through Upgrade Protection or Subscription Plans?
Answer 7: IBM AntiVirus version 3.0.2 is in the process of being shipped to all such customers. As part of our agreement, Symantec will assume responsibility for our contracts, which include these upgrade plans. Symantec plans to contact these customers shortly.
Question 8: I have a Services Agreement with IBM that includes the delivery of IBM AntiVirus, how will this arrangement affect me?
Answer 8: IBM AntiVirus will be withdrawn from marketing and will therefore not continue to be available. However, we are negotiating an agreement with Symantec to allow IBM to distribute Norton AntiVirus for a similar service offering.
Question 9:If someone needs additional information, who should they call?
Answer 9: Regional transition hotlines have been established as follows to answer your questions:
- North America: 1-800-441-7234 or 1-541-334-6054
- Latin America: 1-310-449-7086
- Europe, Middle East, Africa: +353 1 8118032 (Dublin, Ireland)
- Japan: +81 3 3476 1156
- Asia, Pacific: +61 2 9850 1005 (Gladesville, Australia)
Symantec Questions and Answers
1.0 I just purchased IBM's product. How long will virus definition updates be available?
IBM will support virus definition updates through December 31, 1998.
1.1 How do I update my virus definitions
Virus definitions will be available at both IBM and Symantec.
1.2 How do I update my IBM software?
You have just received, or will soon receive, the most recent IBM AntiVirus upgrade from Version 3.0.1 to Version 3.0.2 (internally referenced as build 304). IBM will maintain the level of the product you have just received, or will receive, by continuing to release additional signature files until at least 31 December, 1998. However, no further enhancements or upgrades will be made available from IBM. Symantec will be contacting you shortly to inform you about upgrades to which you may still be entitled. All future IBM AntiVirus customer service and support will be provided by Symantec as your customer contact point.
1.3 What are my support options?
Online support is offered at Symantec's Technical Support site. Phone support is also available at (541) 465-8520. For customer service, call 1-800-441-7234 or (541) 334-6054.
1.4 I have IBM AntiVirus. How do I switch to Symantec's Norton AntiVirus?
Symantec and IBM are developing a conversion tool. The software tool is designed to help customers remove IBM's AntiVirus and install Norton AntiVirus. This tool was designed to be used in an enterprise environment. It runs unattended and can be distributed to client workstations.
1.5 I have IBM AntiVirus. Why should I switch to Norton AntiVirus?
Norton Antivirus includes LiveUpdate allowing customers to easily update their virus definitions and Bloodhound allowing customers to be protected from both know and unknown viruses.
1.6 Norton AntiVirus isn't currently available for OS/2. How will Symantec support current IBM OS/2 customers?
Norton AntiVirus for OS/2 is expected to be available by the end of 1998. Until that time, Symantec will provide IBM's AntiVirus for OS/2 to customers through an OEM agreement with IBM.
1.7 Can I continue using IBM AntiVirus?
Yes. Version 3.0.2 was released to provide IBM customers with a stable platform for this transition. Defect and new signature file support will continue to be provided through December 31, 1998. However, no further development, enhancements or upgrade releases are planned. Should a new type of virus become public, protection would come through Symantec's support. All IBM AntiVirus support expires December 31, 1998
1.8 If customers need licensed code for newly purchased systems as part of a transition plan, will it be available?
Yes. IBM is withdrawing all IBM AntiVirus products from marketing, including additional licenses. However, customers can purchase the right to copy existing code onto additional systems from Symantec.